These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 23839581)

  • 21. Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model.
    Vanden Dries V; Stygelbout V; Pierrot N; Yilmaz Z; Suain V; De Decker R; Buée L; Octave JN; Brion JP; Leroy K
    Neurobiol Aging; 2017 Jul; 55():202-212. PubMed ID: 28464981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective deposition of amyloid-beta protein in the entorhinal-dentate projection of a transgenic mouse model of Alzheimer's disease.
    Su Y; Ni B
    J Neurosci Res; 1998 Jul; 53(2):177-86. PubMed ID: 9671974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD40 ligation mediates plaque-associated tau phosphorylation in beta-amyloid overproducing mice.
    Laporte V; Ait-Ghezala G; Volmar CH; Ganey C; Ganey N; Wood M; Mullan M
    Brain Res; 2008 Sep; 1231():132-42. PubMed ID: 18606155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rapid gene delivery-based mouse model for early-stage Alzheimer disease-type tauopathy.
    Siman R; Lin YG; Malthankar-Phatak G; Dong Y
    J Neuropathol Exp Neurol; 2013 Nov; 72(11):1062-71. PubMed ID: 24128676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation.
    Ashrafian H; Zadeh EH; Khan RH
    Int J Biol Macromol; 2021 Jan; 167():382-394. PubMed ID: 33278431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathological and neurophysiological outcomes of seeding human-derived tau pathology in the APP-KI NL-G-F and NL-NL mouse models of Alzheimer's Disease.
    Tok S; Maurin H; Delay C; Crauwels D; Manyakov NV; Van Der Elst W; Moechars D; Drinkenburg WHIM
    Acta Neuropathol Commun; 2022 Jun; 10(1):92. PubMed ID: 35739575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disruption of corticocortical connections ameliorates amyloid burden in terminal fields in a transgenic model of Abeta amyloidosis.
    Sheng JG; Price DL; Koliatsos VE
    J Neurosci; 2002 Nov; 22(22):9794-9. PubMed ID: 12427835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abeta, tau and ApoE4 in Alzheimer's disease: the axonal connection.
    Adalbert R; Gilley J; Coleman MP
    Trends Mol Med; 2007 Apr; 13(4):135-42. PubMed ID: 17344096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease.
    Ittner LM; Götz J
    Nat Rev Neurosci; 2011 Feb; 12(2):65-72. PubMed ID: 21193853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The usefulness and challenges of transgenic mouse models in the study of Alzheimer's disease.
    Wilcock DM
    CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):386-94. PubMed ID: 20522016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.
    Hurtado DE; Molina-Porcel L; Iba M; Aboagye AK; Paul SM; Trojanowski JQ; Lee VM
    Am J Pathol; 2010 Oct; 177(4):1977-88. PubMed ID: 20802182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.
    Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B
    Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
    Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
    Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of neurofibrillary tangles and tau-associated phenotype in the rTgTauEC model of early Alzheimer's disease.
    Polydoro M; de Calignon A; Suárez-Calvet M; Sanchez L; Kay KR; Nicholls SB; Roe AD; Pitstick R; Carlson GA; Gómez-Isla T; Spires-Jones TL; Hyman BT
    J Neurosci; 2013 Aug; 33(33):13300-11. PubMed ID: 23946388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.
    Oddo S; Caccamo A; Kitazawa M; Tseng BP; LaFerla FM
    Neurobiol Aging; 2003 Dec; 24(8):1063-70. PubMed ID: 14643377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease.
    García-Sierra F; Wischik CM; Harrington CR; Luna-Muñoz J; Mena R
    J Chem Neuroanat; 2001 Jul; 22(1-2):65-77. PubMed ID: 11470555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression.
    Cole AR; Noble W; van Aalten L; Plattner F; Meimaridou R; Hogan D; Taylor M; LaFrancois J; Gunn-Moore F; Verkhratsky A; Oddo S; LaFerla F; Giese KP; Dineley KT; Duff K; Richardson JC; Yan SD; Hanger DP; Allan SM; Sutherland C
    J Neurochem; 2007 Nov; 103(3):1132-44. PubMed ID: 17683481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
    Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
    J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation.
    He Z; Guo JL; McBride JD; Narasimhan S; Kim H; Changolkar L; Zhang B; Gathagan RJ; Yue C; Dengler C; Stieber A; Nitla M; Coulter DA; Abel T; Brunden KR; Trojanowski JQ; Lee VM
    Nat Med; 2018 Jan; 24(1):29-38. PubMed ID: 29200205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.